CannTrust Holdings Inc. (NYSE: CTST, TSE: TRST) was founded in 2015 and is headquartered in Vaughan, Canada, with 212 full-time employees. It is a company that produces and sells medical-grade medical cannabis products in Canada.
CannTrust Holdings Inc. (CTST):
Although marijuana has existed for thousands of years, recent legalization initiatives have made this new industry a new industry. Now, with the full legalization of many developed countries and the acceptance of more and more US medical uses, investors are beginning to tap its growth potential.
CannTrust Holdings Inc., headquartered in Vaughan, Ontario, Canada, produces pesticide-free medical-grade cannabis. They also focus on medical research and collaborate with pharmaceutical companies to innovate and develop products. Revenue quadrupled in 2017, reaching 21 million U.S. dollars. Analysts expect the same level of revenue growth in 2018. They estimate that this year’s income will be approximately $88 million.
CannTrust Holdings Inc. sells dried cannabis and oil extracts to customers based on drug documents provided by healthcare practitioners.
The leader in the medical cannabis industry is Canopy Growth Corp (NYSE: CGC), the world’s largest cannabis grower. With its marketing cooperation with Snoop Dogg and investment from Constellation Brands, Inc. (NYSE: STZ), Canopy attracted Most attention.
Aurora Cannabis Inc. (NYSE: ACB, ACB.TO), another leading Canadian medical marijuana product production and distribution company , is also the focus of the current market. With several successive large-scale acquisitions, it has now ranked second in the industry.